Developing & Evaluating Models for Early Predicting Obstetrical Diseases in Pregnant Women by Non-invasive Prenatal Test
- Sponsor
- Gene Solutions
- Study ID
- NCT06385366
- Status
- Enrolling By Invitation
Conditions
- Gestational Diabetes
- Preeclampsia
- Pregnant With Complication
- Preterm Birth
Eligibility Criteria
- Sex
- FEMALE
- Age
- 18 Years - 80 Years
- Healthy Volunteers
- Not accepted
Study Details
This is Observational study, aiming to investigate the potentiality of cffDNA and cfRNA by a non-invasive test, in combination with clinical characteristics, to establish models for early screening and predicting high-risk pregnancy of PE, SPB, and GDM in Vietnam.
Key Dates
- First listed
- Apr 26, 2024
- Start date
- May 10, 2024
- Status verified
- Jul 2025
- Primary completion
- Nov 6, 2025
- Completion
- Nov 6, 2025
Study Design
- Enrollment
- 1,105 participants (estimated)
Primary Outcome Measure
Characteristics of pregnant women at 1st trimester (9-13 weeks 6 days of gestation) [ Time Frame: 12 months ]
Related Studies
- Effects of High Altitude on AMPK ActivationRecruiting · University of Colorado, Denver · Aurora, Colorado
- Continuous Positive Airway Pressure (CPAP) for Sleep Apnea in PregnancyRecruiting · The George Washington University Biostatistics Center · Birmingham, Alabama
- Latency Antibiotics in Previable PPROM, 18 0/7- 22 6/7 WGAPHASE4 · Recruiting · Woman's · Baton Rouge, Louisiana
- Exosome Cargo From Preeclampsia PatientsRecruiting · University of Alabama at Birmingham · Birmingham, Alabama